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ABSTRACT OF THE DISSERTATION 
 
Towards Early Glioblastoma Detection: 
In Vivo MR Imaging and Spin Dynamics Simulations 
 
by 
 
Guan Wang 
Master of Science in Chemistry 
University of California, Los Angeles, 2019 
Professor Louis Bouchard, Chair 
 
Early detection of high-grade malignancy, such as glioblastoma (GBM), using new 
contrast mechanism and enhanced magnetic resonance imaging (MRI) techniques increases the 
treatment options available, and therefore may expand survival in GBM beyond the natural 
history of the disease and possibly increase the patients’ survival rate. To achieve early detection, 
it is important to evaluate commonly used MRI techniques, as well as to develop a theoretical 
model of GBM growth to predict the consequential changes in MR parameters and to evaluate 
the performance of newly developed MRI techniques. For this purpose, popular MRI methods 
such as the spin-echo, the Carr-Purcell-Meiboom-Gill (CPMG), and the spin-locking radio-
iii 
 
frequency (RF) pulse sequences were used to acquire in vivo T2-weighted and T1U-weighted MR 
images of orthotopic GBM mouse/rat models from U87MG and C6 cell lines. Statistical results 
(N = 18) showed that, while the spin-echo T2-weighted MR imaging may not provide the 
required contrast to detect early GBM, the CPMG T2-weighted MR imaging and the spin-locking 
T1U-weighted MR imaging did slightly improve the early GBM contrast, but at the cost  of 
significantly elevated specific absorption rate (SAR) and increased potential risk, if applied to 
human patients. To facilitate the development of innovative MRI RF pulse sequences to enhance 
early GBM contrast with low SAR, a simple, computationally efficient theoretical model on 
early GBM was proposed based on the experimental observation that vessel density decreases 
together with the increase of vessel size during the early stage of the GBM growth. Based on this 
model, Monte Carlo spin dynamics simulations were carried out by solving the Bloch equations 
for the water magnetizations diffusing in the magnetic-field gradients induced by paramagnetic 
deoxyhemoglobin in the vessels. The interplay among the spin dynamics, early GBM contrast, 
RF pulse sequences, vessel distributions, and GBM staging can be numerically evaluated. The 
simulated early GBM contrast and the relaxation time constants, T2 and T1U, from the spin-echo, 
the CPMG, and the spin-locking RF pulse sequences were compared with those from the in vivo 
MR imaging of orthotopic early GBM mouse models to study the relaxation mechanisms. It may 
also serve as a computationally efficient alternative for laboratory use of animals following the 
3R (reduction, refinement and replacement) strategy in evaluating the performance of commonly 
use or newly developed MR methods for early GBM detection. 
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Figure 1. Development of GBM contrast in one orthotopic U87MG mouse model during its 
clinical course, as acquired by popular MRI pulse sequences. For late-stage GBM (e.g., 30 days 
after tumor implantation), the metabolic by-products from the GBM cells' mitosis and growth 
increase the local osmotic gradient of the extracellular fluid. This results in the ingress of fluid 
from the intravascular space to increase the T2 time constant and decrease the T1 time constant to 
make GBM detectable in the spin-echo T2-weighted images and the gadolinium-enhanced 
inversion-recovery T1-weighted images, respectively. 
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Figure 2. Development of GBM contrast in four orthotopic C6 rat models during its clinical 
course, as acquired by the spin-echo pulse sequences. For the same slice position, while the 
GBM area is highlighted by the positive contrast on Day 18 (late-stage GBM), the tumor is 
indistinguishable from surrounding tissues on Day 12 (earlier-stage GBM). Contrast-to-noise 
ratios (CNR) of the GBM is labeled on images acquired on Day 18. 
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Figure 3.  MRI RF pulse sequences used in this work with different preparation scheme: (A) 
Fast spin-echo (FSE) pulse sequence; (B) Spin-echo T2-weighted imaging: prepared by the spin-
echo pulse sequence and acquired by FSE (C) CPMG T2-weighted imaging: prepared by the 
CPMG pulse sequence and acquired by FSE; (D) Spin-locking T1U-weighted imaging: prepared 
by the spin-locking pulse sequence and acquired by FSE. For simplicity, gradient pulses for 
phase encoding and decoding are not shown. Experimental parameters are given in section 4.3. 
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Figure 4.  The relaxation time constants of the normal brain tissue (averaged from left normal 
brain tissue) and the GBM, acquired by the spin-echo (Figure 3B, TE = 10, 30, 50, 70, and 90 
ms), the CPMG (Figure 3C, τCP = 8 ms), and the spin-locking (Figure 3D, B1 = 125 Hz) pulse 
sequences from Day 3 to Day 28 after implantation of U87MG cells to the right brain of mouse. 
The linear regressions of the normal brain tissue relaxation time constants are (in ms): T2,SEbrain =
−5.47 × 10−3 × days + 42.30, T2,CPMGbrain = 6.12 × 10−2 × days + 57.85, and T1ρ,   SLbrain =
−8.62 × 10−2 × days + 58.50, respectively. The linear regressions of the early-stage GBM 
(i.e., within 15 days after tumor implantation) relaxation time constants are (in ms): T2,SEGBM =
−0.35 × days + 43.41, T2,CPMGGBM = −0.025 × days + 63.89, and T1ρ,SLGBM = 0.55 × days + 64.60, 
respectively. The linear regression of the late-stage GBM (i.e., more than 15 days after tumor 
implantation) relaxation time constants are (in ms): T2,SEGBM = 0.69 × days + 32.77, T2,CPMGGBM =
0.56 × days + 62.28, T1ρ,SLGBM = 1.68 × days + 40.80. 
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Figure 5.  Development of the GBM contrast in orthotopic U87MG mouse models during its 
clinical course, as acquired by the spin-echo (Figure 3B, TE = 30 ms), the CPMG (Figure 3C, τCP 
= 8 ms, n = 4, and τCP = 1 ms, n = 32), and the spin-locking (Figure 3D, B1 = 125 Hz, TSL = 30 
ms, and B1 = 2000 Hz, TSL =  70 ms) pulse sequences. CNR of the GBM is labeled on each 
image. At both early stage (within 15 days after tumor implantation) and late stage (more than 15 
days after tumor implantation), the images acquired by CPMG and spin-locking show superior 
GBM contrast than those acquired by spin-echo. For late-stage GBM, the metabolic by-products 
from the GBM cells’ mitosis and growth increase the local osmotic gradient of the extracellular 
fluid. This results in the ingress of fluid from the intravascular space to increase the T2 time 
constant to make GBM detectable in the spin-echo T2-weighted images. 
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Figure 6. T2 and T1U time constant mappings for 4 mice at different days after tumor 
implantation, fitted from images acquired by the spin-echo (Figure 3B, TE = 10, 30, 50, 70, and 
90 ms), the CPMG (Figure 3C, τCP = 8 ms and 1 ms, n = 2, 4, 8, 16, 32), and the spin-locking 
(Figure 3D, B1 = 125 Hz and 2000 Hz, TSL = 10, 30, 50, 70, 100 ms) pulse sequences. The 
average T2 and T1U time constants of the normal left brain tissue and the GBM (circled in red) 
are given in blue and red, respectively. 
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Figure 7. 3-D magnetic field distribution for a voxel with (A) 1 vessel-cylinder and (B) 9 vessel-
cylinders. The color map shows the z-component of the magnetic field (Bz) generated by vessel 
cylinder(s) with blood volume fraction Bvf = 0.04. Outside the vessel, as described in Equation 
2, Bz rapidly decreases with the distance from the vessel cylinder. 
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Figure 9. T2 and T1U time constants of the three pulse sequences (spin-echo, CPMG, and spin-
locking) for various field distributions (1, 2, 4, and 9 vessel-cylinders) with constant BVf = 0.04. 
For each pulse sequence, two simulation methods were used and the results from the two 
methods converged. The background T2 and T1U relaxation parameters used for spin-echo, 
CPMG, and spin-locking are 55 ms, 70 ms, and 65 ms, respectively. 
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1. Introduction 
 Glioblastoma (also called glioblastoma multiforme, GBM) is one of the most challenging 
diseases to treat in clinical oncology due to its high mortality rates and inefficient conventional 
treatment methods [1]. Difficulties with early detection, intra-tumor heterogeneity [2-4], post-
surgical recurrences [5], and resistance to chemotherapy and radiotherapy [6] are important 
reasons for the poor prognosis of those with GBM. Many studies have shown that current 
therapies, including surgery, chemotherapy, radiotherapy, gene therapy [7], and immunotherapy 
[8, 9], extended patient survival in GBM beyond that allowed by the natural course of the 
disease. Despite the development of treatment options, the 5-year survival rate reported most 
recently is only 5.6% [10]. In the vast majority of cases, GBMs are ultimately incurable, as they 
are typically detected far too late in their clinical course, as illustrated in Figure 1 and Figure 2 
using orthotopic U87MG mouse models and C6 rat models, respectively. For late-stage GBM, 
the metabolic by-products from the GBM cells' mitosis and growth increase the local osmotic 
gradient of the extracellular fluid. This results in the ingress of fluid from the intravascular space 
to increase the magnetic resonance (MR) T2 time constant and decrease the MR T1 time constant, 
making GBM detectable in the spin-echo T2-weighted MR images and the inversion-recovery 
T1-weighted MR images, respectively. Unfortunately, by the time GBM becomes symptomatic, 
it is almost always too late in its biological course such that isolated tumor/stem cells would have 
migrated far beyond the MR imaging-defined tumor mass. These motile cells will ultimately 
establish additional tumor nidus in the margin of the resection, at some distance away from the 
margin, or even in the opposite hemisphere. At this time, no effective prevention or early MR 
imaging for GBM is available. 
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Early detection of cancer may improve survival rate and decrease morbidity. This is of 
great importance for high-grade malignancy such as GBM. The goals for early cancer detection 
is to find them when they are small, find them when they are local, find them before they turn 
malignant, and find them when they may still be curable by some minimally invasive surgical 
method or even by stereotactic radiation methods such as brachytherapy or radiosurgery. Many 
studies have shown that current therapies (surgery, radiation, chemotherapy, etc.) expand 
survival in high-grade malignancy beyond the natural history of the disease [11]. For example, 
according to a study conducted by Yabroff et al. [12], for adult GBM patients treated with both 
chemotherapy and radiotherapy, the median survival was approximately 15 months; for patients 
who received either chemotherapy or radiotherapy, the median survival dropped to 7 months; for 
patients who did not receive any standard treatment, the median survival was only 2 months. 
Moreover, Ohgaki et al. [13] reviewed population-based studies on survival rates in astrocytic 
and oligodendroglial gliomas, and found that the median survival time for patients diagnosed 
with astrocytoma that was still at low-grade was 5.6 years, but for patients diagnosed with 
astrocytoma that has progressed from low-grade glioma to the high-grade GBM was only 4.9 
months. Consequently, early detection of high-grade malignancy, such as glioblastoma (GBM), 
using new contrast mechanism and enhanced MRI techniques increases the treatment options 
available, and therefore may expand survival in GBM beyond the natural history of the disease 
and possibly increase the patients’ survival rate.   
In this work, we first presented in vivo T2-weighted and T1U-weighted MR images of 
orthotopic GBM mouse models infected with human U87MG cell line and orthotopic GBM rat 
models infected with C6 cell line, respectively. Two cell lines were used in this work to confirm 
the scientific validity and general applicability of our study and conclusion. Since tumor models 
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created by different cell lines may generate differences in evolution and MR parameters, it is 
important to study different experimental tumor models in in vivo and preclinical trials. We then 
presented in vivo MR images of the above-mentioned orthotopic GBM mouse/rat models 
acquired by the commonly used spin-echo, Carr-Purcell-Meiboom-Gill (CPMG), and spin-
locking RF pulse sequences. Statistical results (N = 18) showed that spin-echo T2-weighted MR 
imaging may not provide the required contrast to detect early GBM. The CPMG T2-weighted 
MR imaging and the spin-locking T1U-weighted MR imaging could slightly improve early GBM 
contrast, but at the cost of elevated specific absorption rate (SAR) and increased potential risk to 
the patients. This is not suitable to detect early-stage diseases, which requires a proven, safe, and 
acceptable screening technique.  
Building a realistic and flexible biophysical model for early GBM is important, not only 
to accelerate the development of innovative MRI pulse sequences for early GBM detection with 
low SAR, but also to provide an alternative for laboratory use of animals following the 3R 
(reduction, refinement, and replacement) strategy. Over the past two decades, several analytical 
methods of functional MRI (fMRI), such as cerebral blood volume mapping (CBV), positron 
emission tomography (PET), and blood oxygenation level-dependent (BOLD) imaging , have 
been studied, in which fMRI uses intrinsic signal-change of NMR to develop and enhance the 
contrast originated from magnetic susceptibility. Most of the current papers on BOLD signal in 
the literature focus on improving the models, and yet, few of them describe the relationship with 
realistic early GBM relaxation. Thus we propose the first model for early GBM and normal brain 
tissue inspired by Ogawa et al. [14], in which the relationship between the transverse relaxation, 
pulse sequences used for imaging, and vessel distributions can be evaluated.  
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Through in vivo and ex vivo study on rat model of C6 glioma, Valable et al. [15] found 
that the blood volume fraction (BVf) in the tumor center and periphery remained nearly 
unchanged until day 20, while the vessel size index in the tumor kept increasing until day 25 and 
became significantly higher than that in the contralateral striatum on day 11. Combining these 
experimental observations that BVf remained about the same while the average vessel size 
increased with the GBM growth and the BOLD model, we proposed a simple, computationally 
efficient theoretical model for MRI studies on early GBM. Using the proposed model, Monte 
Carlo spin dynamics simulations were carried out by solving the Bloch equations for the water 
magnetizations diffusing in the magnetic-field gradients induced by paramagnetic 
deoxyhemoglobin in the vessels. The interplay among the spin dynamics, GBM contrast, RF 
pulse sequences used for imaging, vessel distributions, and GBM staging can be numerically 
evaluated. The simulated early GBM contrast and relaxation time constants, T2 and T1U, from the 
spin-echo, the CPMG, and the spin-locking RF pulse sequences were then compared with those 
from in vivo MR imaging of orthotopic early GBM mouse models to study the relaxation 
mechanisms. To the best of our knowledge, the proposed work is the first GBM computational 
model based on the previous pathological finding of increase in vessel size, while maintaining 
similar blood vessel volume fraction. It allows semi-quantitative and qualitative comparison with 
in vivo MR images and provide a simple, computationally efficient alternative in evaluating the 
performance of commonly use or newly developed MR methods for early GBM detection.  
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2. Results 
2.1. In Vivo MR Imaging 
To evaluate the feasibility of using existing popular MRI RF pulse sequences for early 
GBM detection, a GBM mouse model (N = 18) was established using an intracranial inoculation 
of U87MG cells. The imaging studies were performed from Day 3 through Day 28 following 
tumor inoculation. A Varian INOVA 7-T high-resolution NMR spectrometer equipped with a 
30-mm I.D. Varian Millipede micro-imaging probe was used for the investigations. The RF pulse 
sequences used in this work are shown in Figure 3. Since this micro-imaging system has superior 
static and RF field homogeneity, and accurate RF flip angle calibration, the choice of the spin-
echo (Figure 3B), the CPMG (Figure 3C), and the spin-locking (Figure 3D) pulse sequences to 
prepare the spin system to high-contrast states (then acquired by fast spin-echo) is mainly to 
compare their sensitivity in detecting early GBM by various rephasing mechanisms. 
Figure 4 shows the relaxation time constants, T2 and T1U, of the GBM and the normal 
brain tissue, as acquired by the spin-echo (SE, Figure 3B), the CPMG (Figure 3C, τCP = 8 ms), 
and the spin-locking (SL, Figure 3D, B1 = 125 Hz) RF pulse sequences, respectively. The 
observed T2 time constant by the spin-locking pulse sequence is commonly referred as T1U [16, 
17]. The linear regressions of the normal brain tissue relaxation time constants are (in ms): 
T2,SE
brain = −5.47 × 10−3 × days + 42.30, T2,CPMGbrain = 6.12 × 10−2 × days + 57.85, and 
T1ρ,   SL
brain = −8.62 × 10−2 × days + 58.50, respectively. It is clear that the relaxation time 
constants of the normal brain tissue remain constant over the course of the GBM growth, 
regardless the MR techniques used. For example, the average T2 time constant of the normal 
brain tissue for the most commonly used MR pulse sequence, the spin-echo pulse sequence 
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(Figure 3B), is T2,SEbrain = 42.24 ms, with a standard deviation 0.88 ms. On the other hand, the 
linear regression of the GBM T2 time constants over the course of the GBM growth from Day 3 
to Day 28 is found to be (in ms) T2,SEGBM = 0.35 × days + 38.51, consistent with the experimental 
observation that GBM generates brighter T2 contrast as it grows. To distinguish early-stage 
GBM, we define time constant threshold for hyperintensity as one standard deviation higher than 
the average T2 of the normal brain, which is found to be 15 days after tumor implantation. The 
linear regressions of early-stage GBM (i.e., earlier than 15 days after tumor implantation) 
relaxation time constants are (in ms): T2,SEGBM = −0.35 × days + 43.41, T2,CPMGGBM = −0.025 ×
days + 63.89, and T1ρ,SLGBM = 0.55 × days + 64.60, respectively. 
To eliminate the effect from tumor injection to the differences in MR parameters between 
the GBM and the normal brain tissue, we have also carried out control experiment in which only 
PBS solution was injected into the mouse brain. The average T2 time constants obtained from the 
spin-echo T2-weighted images (Figure 3B) of the PBS area and the normal brain tissue were 
fitted to be (T2 for PBS area was listed first): 42.1 ms and 42 ms (Day 1); 41 ms and 41.8 ms 
(Day 2); 36 ms and 41.1 ms (Day 3); 39.4 ms and 40.7 ms (Day 6.5); 39.9 ms and 42.2 ms (Day 
8); 40.1 ms and 41.7 ms (Day 19). The results show that the damage to the brain by the needle 
and the insertion of a certain volume of fluid do not contribute significantly to the difference in 
the MR parameters between the GBM and the normal brain tissue, and the difference we 
observed can be attributed to the GBM and its growth.  
For visual comparison, Figure 5 and Figure 6 show representative T2-weighted and T1U-
weighted MR images and time-constant mappings from four different mice, acquired by the spin-
echo (Figure 3B), the CPMG (Figure 3C), and the spin-locking (Figure 3D) RF pulse sequences 
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on Day 3, Day 9, Day 20, and Day 22, respectively. For each of CPMG and spin-locking, two 
sets of experimental parameters were used: τCP = 8 ms and 1 ms (half of CPMG inter-pulse 
spacing), and B1 = 125 Hz and 2000 Hz (spin-locking field strength), to investigate how RF 
power affect the detection sensitivity. For the spin-echo pulse sequence, the nearly 
indistinguishable T2 parameters (Figure 4A) and a visual inspection on Figure 5 and Figure 6 
(first column) suggest that it may not provide the required contrast to detect early GBM. On the 
other hand, the CPMG T2-weighted MR imaging with short echo spacing (e.g., τCP = 1 ms) and 
the spin-locking T1U-weighted MR imaging with high locking-field (e.g., B1 = 2000 Hz) slightly 
improve early GBM contrast. For late-stage GBM (more than 15 days after tumor implantation), 
contrasts are enhanced greatly for all pulse sequences as edema evolves and the local magnetic 
environment of the GBM becomes drastically different from that of the normal brain tissue. 
 
2.2. Spin Dynamics Simulations 
 Monte Carlo spin dynamics simulations were carried out by solving the Bloch equations 
for the water magnetizations diffusing in the magnetic-field gradients induced by paramagnetic 
deoxyhemoglobin in the vessels, as described in details in sections 4.5-4.9. The interplay among 
the spin dynamics, GBM contrast, RF pulse sequences used for imaging, vessel distributions, and 
GBM staging can be numerically evaluated. As mentioned in the Introduction, based on the 
experimental observation by Valable et al. [15] that BVf remained about the same while the 
average vessel size increased with the GBM growth (until very late stage), 1 vessel-cylinder and 
9 vessel-cylinders with the same BVf were chosen to represent the later stage and the earlier 
stage of the GBM growth, respectively. Using the form of the magnetic field given by Equation 
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2, 3D plots of the magnetic field created by 1 vessel-cylinder and 9 vessel-cylinders, 
respectively, are shown in Figure 7. The color map shows the z-component of the magnetic field 
(Bz) generated by vessel-cylinder(s) with the same Bvf = 0.04. For both cases, it is clear that 
water magnetizations experience a rapidly decreasing Bz with distance from the vessel-cylinder 
when they are moving outside the vessel. The differences in the magnetic field distribution 
created by 1 vessel-cylinder and 9 vessel-cylinders are further discussed in Figure 8. While the 
field distribution of Bz for 9-vessel-cylinder voxel and 1-vessel-cylinder voxel is almost the same 
(Figure 8A), the change in Bz per random walk step for a voxel with 9 vessel-cylinders shows a 
broader distribution than that for a voxel with 1 vessel-cylinder (Figure 8B).  
The relation between vessel cylinder distribution and T2 and T1U time constants is 
summarized in Figure 9. The figures inserted above the number of vessel-cylinder(s) are the 
corresponding magnetic field distributions. Fewer, larger vessel cylinders represent the later 
stage of the GBM growth. Vessel-cylinders are distributed such that the distance between nearest 
pairs remains constant across voxels when aligned periodically. Vessel-cylinder radius varies 
with the number of vessel cylinders from 9×10-6 m to 3×10-6 m to maintain constant BVf = 0.04 
for the four cases. Background T2 and T1U relaxation parameters in the Bloch equation are 
chosen by comparing with experimental results shown in Figure 4. The background T2 and T1U 
relaxation parameters used for spin echo, CPMG, and spin locking are 55 ms, 70 ms, and 65 ms, 
respectively. As mentioned in sections 4.6-4.9, for each pulse sequence used (spin-echo, CPMG, 
and spin-locking), two simulation methods were used to prove accuracy and provide 
computational efficiency. It is clearly shown in Figure 9 that the results from the two methods 
converge to within 1.5%. Agreement between different methods indicates that simulations are 
consistent in our model. 
9 
 
3. Discussion 
3.1. Relaxation Mechanism 
 The dephasing mechanisms for water magnetizations diffusing among magnetic 
nanoparticles in a system have been extensively studied in the last two decades [18]. In the 
absence of a refocusing pulse, the dephasing mechanisms of the water magnetizations can be 
grouped into two regimes, depending on the size of the magnetic nanoparticles: the motional 
averaging regime (small particle sizes) and the static dephasing regime (large particle sizes). 
Static dephasing regime was originally proposed to describe the magnetic nanoparticles with 
smaller magnetic field gradient and large inter-particle distance compared to the diffusion 
distance experienced by the water magnetizations nearby. Subsequently, the resulting relaxation 
rate will not be affected by the random walk of the water magnetization and will approach a 
static limit. For large magnetic particles in the static dephasing regime, phase dispersion of 
surrounding water magnetizations may be partially refocused using spin echo techniques, which 
is referred to as the slow motion regime. In this work, we extend the dephasing mechanism 
induced by large magnetic nanoparticles under refocusing pulses (i.e., the slow motion regime) 
to the dephasing of the water magnetizations in our vessel-cylinder model.  
A refocusing RF pulse is a 180o pulse that is applied at time TE/2 (in the spin-echo pulse 
sequence) or τCP (in the CPMG pulse sequence) after the initial excitation pulse. During 
diffusion, water magnetizations experience magnetic field gradients, which in turn dephase the 
ensemble by letting water magnetizations precess at different precession frequencies. When the 
ensemble of water magnetizations is partially rephased by the 180o pulses, the phases are 
reversed back in time to some extent by reversing the order of the fast and the slow components, 
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and dephasing is partially diminished along this process. Therefore, the fast decay between t = 0 
and t = τCP will be partially recovered after the 180o pulse, and the signal after τCP increases and 
peaks at TE = 2 τCP, which is referred to as the "echo" of the original signal. Fitting the 
exponential decay function over these echo amplitudes results in a decay much slower than the 
decay between echoes and the resulting decay rate, R2, is significantly lower than the cases when 
there is no refocusing 180o pulse.  
In the presence of refocusing 180o pulses, the relaxation depends on the extent of 
rephasing. The refocusing is more effective when more water magnetizations are localized to a 
consistent local magnetic field. Therefore, the longer time water magnetizations can freely 
evolve under a varying field, the more dephasing occurs, i.e., shorter pulse spacing yields lower 
R2 rates (longer T2 relaxation time) than longer ones. An analogy can be established between 
CPMG and spin-locking in that spin-locking operates with consecutive rephasing pulses at an 
even shorter τCP in this experiment. The frequent refocusing in spin-locking makes the difference 
in field distributions most pronounced and in turn generates the best contrast [16, 17]. Our in 
vivo experimental results and simulation results suggest that the relaxation mechanism in the 
GBM and the normal brain tissue, in which the blood vessels generate local magnetic field 
gradients and lead to the loss of phase coherence among the water magnetizations nearby, can be 
understood by the slow motion regime. Experimental results from Figure 5 and Figure 6 show 
that the CPMG and the spin-locking pulse sequences suppress the relaxation for both GBM (at 
any stage) and normal brain tissue, compared to the spin-echo pulse sequence, and the shorter the 
inter-pulse spacing (or the stronger the B1 locking field), the more the relaxation is suppressed. 
This trend is confirmed by the computer spin dynamics simulation results shown in Figure 9, 
where we simulated 1, 2, 4, and 9 vessel-cylinders to mimic normal brain tissue and different 
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stages of the GBM growth. Such observations are consistent with the relaxation scheme in the 
slow motion regime described above. 
 
3.2. SAR Concerns 
 Although the CPMG T2-weighted MR imaging with short inter-pulse spacing (e.g., τCP = 
1 ms) and the spin-locking T1U-weighted MR imaging with high locking-field (e.g., B1 = 2000 
Hz) slightly improve early GBM contrast, as shown in Figure 5 and Figure 6, it is at the cost of 
elevated specific absorption rate (SAR) and increased potential risk to the patient [19]. In the 
clinical MRI scans on brain tumor patients, the inter-pulse spacing chosen in the CPMG pulse 
sequence is usually longer than 7 ms [20-22]. Therefore, the short inter-pulse spacing CPMG and 
high locking-field spin-locking pulse sequences that generated improved contrast in the 
presented work, if applied to human patients, may raise potential risk due to elevated SAR. In 
addition, special attention on SAR needs to be paid for GBM patients, as previous study showed 
that peak local SAR estimation using a healthy patient model may be lower than the true peak 
local SAR in a brain tumor patient [23]. 
 
3.3. Vessel Density Dependence 
 As shown in Figure 7, the strength of the induced magnetic field gradients depends on 
spatial locations. Water magnetizations experience the strongest magnetic field gradients when 
they diffuse around the vessel-cylinders. As mentioned previously, T2 relaxation in the slow 
motion regime depends on the extent of refocusing. Similar to how more frequent refocusing 
12 
 
pulses suppress the T2 relaxation, the more the water magnetizations are localized in a relatively 
homogeneous magnetic-field area, the more effective the refocusing is. Therefore, the refocusing 
is more effective for water magnetizations surrounding large vessels than those surrounding 
small vessels where the water magnetizations diffuse to a different magnetic environment more 
easily. In the 1-vessel-cylinder case where the radius is the largest, magnetic field gradient is 
weaker compared to the multiple-vessel-cylinder case, as indicated in Figure 8. Thus water 
magnetizations in the 1-vessel-cylinder voxel would need to diffuse the most steps in order to 
experience large gradient. For the 9-vessel-cylinder case, the dipolar field fluctuates strongly 
near each vessel cylinder, and water magnetizations only need to diffuse a few steps to 
experience a significant change in the magnetic field. The change in T2 relaxation per cylinder, 
∆T2
∆C
, decreases as the density of cylinder increases for all pulse sequences, where ∆C is the change 
in the number of vessel cylinders. This diminution in the effect of vessel density variation can be 
attributed to the decreasing difference in vessel cylinder radius as discussed in Boxerman et al. 
[24, 25]. 
 
3.4. Validity and Accuracy of the Model 
 Rigorous theoretical modeling on GBM growth is complex, as there are many 
pathological changes with GBM growth that may affect the MR observables and spin dynamics. 
To provide a simple and computationally efficient theoretical model for future studies, especially 
for the development of much more sensitive MRI pulse sequences and imaging modalities for 
early GBM detection, in this study we focused on the major difference between the early and the 
late stages of the GBM growth, i.e., the increase in vessel size. The differences in vascular 
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permeability, blood volume fraction, and magnetic susceptibility between the normal brain tissue 
and GBM were assumed to be negligible in the early-stage GBM. Vessel network orientations 
may take important role on induced magnetic field; however, the effect may not be as important 
in the study of very early stage of GBM formation, due to the small voxel-size in this case, 
compared to the previous study by Martindale et al. [26].  
The transverse (T2) relaxation of the average magnetization of the spin ensemble mainly 
originates from the fluctuating local magnetic fields experienced by the water protons, due to, for 
example, diffusion in macroscopic and microscopic magnetic field gradients, magnetization 
transfer, and spin-spin "flip-flop". In computer spin dynamics simulations, we focus on the 
dephasing due to the water magnetizations diffusing in the magnetic-field gradients induced by 
paramagnetic deoxyhemoglobin in the vessel-cylinders and collectively describe the other 
mechanisms by a phenomenological background relaxation to provide a simple and 
computational efficient theoretical model. Consequently, the GBM contrast observed in the spin-
echo T2-weighted images, the CPMG T2-weighted images, and the spin-locking T1U-weighted 
images originate not only from the difference in the magnetic field gradients from the vessel-
cylinders, but may also from the background relaxation mechanisms. Among various 
background relaxation mechanisms, the contribution from the T1 relaxation process should be 
insignificant, due to the long T1 time constants in biological tissues (> 1 s) and the similar T1 
time constants between the GBM and the normal brain tissues. 
On the other hand, magnetization transfer (MT) is likely to contribute to the observed 
GBM contrast. MT describes the interactions between "free" water protons and "restricted" water 
protons that are bound to proteins or other macromolecules. MT can occur either by direct 
chemical exchange or by indirect dipole-mediated cross relaxation between macromolecular 
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protons and water protons -- both processes are known to be important in biomedical tissue [27-
34]. Selective saturation of the characteristically short T2 macromolecular proton pool can 
produce contrast called magnetization transfer contrast, based on the exchange or cross-
relaxation process. MT contrast has been shown to be positively correlated with tumor grade and 
cellularity [31-34]. Selective saturation can be achieved with continuous wave irradiation several 
kHz off resonance or short, intense G-pulses on resonance. Therefore, the spin-echo, the CPMG, 
and the spin-locking pulse sequences used in this work to prepare the spin systems to high-
contrast states may accidentally generate MT-weighted imaging. In particular, spin-locking can 
easily produce MT contrast [35] and CPMG is equivalent to spin-locking in the limit of short 
inter-pulse spacing, τCP [36].  
Our model can be further refined by incorporating more detailed information and 
complicated dynamics. For example, more accurate early GBM models that take into account 
other effects, such as the vessels becoming more disorganized and randomly oriented when 
GBM grows, changes in the diffusion coefficient of water magnetizations, the increase of 
vascularization in the periphery, and the MT effect, are under development in our lab now. 
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4. Materials and Methods 
4.1. Orthotopic GBM Mouse Model by U87MG Cell Line 
 Six-week-old male NOD CB17-Prkdscid/IcrCr1B1tw (NOD/SCID) mice were obtained 
from BioLASCO Experimental Animal Center (BioLASCO, Taiwan) and bred in a specific 
pathogen-free room in the animal facility. All animal procedures were in accordance with the 
regulations approved by the Institution Animal Care and Utilization Committee (IACUC) at 
National Taiwan University (project identification number: NTU-103-EL-61; date of approval: 
10/2014). All operations were performed under anesthesia and all possible effort has been made 
to minimize pains/suffering of the mice. The U87MG cell line used was purchased from 
Bioresource Collection and Research Center (BCRC, Taiwan), which was derived from 
American Type Culture Collection (ATCC). U87MG cell line was chosen because it is one of the 
most commonly used cell lines in human glioma research. Although a recent study conducted by 
researchers from the laboratory in which U87MG cell line was established found that the 
commercially available version of U87MG (from the ATCC) not identical to its patient of origin, 
U87MG is still believed to be a bona fide human glioblastoma cell line of unknown patient 
origin [37]. It is likely a glioblastoma of central nervous system (CNS) origin. 
For tumor implantation, each NOD/SCID mouse was anesthetized with Ketalar (40 
mg/kg) and Rompun (15 mg/kg) and placed in a stereotactic frame for accurate location of 
implantation. U87MG cells (5 × 105 cells, 5 μL per mouse) were orthotopically inoculated into 
the center of caudate putamen of the mouse (2.5 mm to the right of bregma, and depth = 3.0 mm). 
During the imaging acquisition, vital signs of the mouse under anesthesia (about 5% isoflurane 
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induction, 2% for maintenance in air) was monitored. The flow rate of isoflurane was carefully 
adjusted to maintain stable heart rate and respiratory rate. 
A total of 30 mice were used in this study. One mouse died in the GBM implantation 
surgery, one mouse was bored a large hole during the surgery, one mouse did not grow GBM, 5 
mice encountered hydrocephalus (caused by U87MG cells being injected into lateral ventricle), 
and the GBM implantation was considered not successful in 4 mice for other reasons. Thus the 
mice in vivo results shown in this paper were obtained from the other 18 mice. Each mouse was 
measured every 4-7 days between Day 3 and Day 30 to make sure that they have sufficient rest 
between MR measurements and to fit into the limited MRI machine time available. Nine (9) 
mice were measured throughout the whole time period, while the other 9 were measured in early 
stage of the GBM growth only due to death or sacrifice (when GBM became too big). 
 
4.2. Orthotopic GBM Rat Model by C6 Cell Line 
 9-week-old male Sprague-Dawley and Wistar rats were obtained from National 
Laboratory Animal Center of Taiwan and bred in a specific pathogen-free room in the animal 
facility. No significant difference in tumor growth rate and MR results was observed between 
these two strains used in the rat experiment. All animal procedures were in accordance with the 
regulations approved by the Institution Animal Care and Utilization Committee (IACUC) at the 
Institute of Biomedical Sciences, Academia Sinica (protocol ID: 17-02-1050). All operations 
were performed under anesthesia and all possible effort has been made to minimize 
pains/suffering of the rats. The C6 cell line used was purchased from Bioresource Collection and 
Research Center (BCRC, Taiwan), which was derived from American Type Culture Collection 
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(ATCC). For tumor implantation, each rat was placed in a stereotactic frame for accurate 
location of implantation. C6 cells (0.9 × 105 cells, 0.6 μL per rat) were orthotopically inoculated 
into the striatum of the rat (Bregma = 0.2 mm, lateral = 3.0 mm, and depth = 5.0 mm) using a 30-
gauge needle (Hamilton, NV, USA). The GBM implantation in all 4 rats was successful. MR 
images on all 4 rats were acquired 12 and 18 days after the GBM implantation. 
 
4.3. In Vivo MR Imaging Acquisition 
 All in vivo mouse MR images were acquired by a Varian INOVA 7-T NMR spectrometer 
(Varian Inc., USA) equipped with a 30-mm I.D. Varian Millipede micro-imaging probe and self-
shielded gradient systems with a maximum strength of 100 G cm-1 in each direction (Resonance 
Research Inc., USA). Images were prepared by the spin-echo (Figure 3B), the CPMG (Figure 
3C), and the spin-locking (Figure 3D) pulse sequences to high contrast states and then acquired 
by the fast spin-echo (FSE) pulse sequence (Figure 3A) with repetition time (TR) = 7.5 s, 
number of scans (NS) = 1, echo spacing = 10 ms, number of echos = 8, field of view (FOV) = 
2.56 cm × 2.56 cm, matrix size = 128 × 128, zero padding = 512 × 512, and slice thickness = 0.8 
mm. For the spin-echo pulse sequence (Figure 3B), echo time (TE) = 10, 30, 50, 70, and 90 ms, 
respectively. For the CPMG pulse sequence (Figure 3C), τCP = 8 ms, 1 ms, and number of 180o 
pulses (n) = 2, 4, 8, 16, 32, respectively, where τCP is half of the interval between successive 180o 
pulses in a CPMG sequence (τCP = TE/2). For the spin-locking pulse sequence (Figure 3D), 
locking field B1 = 125 Hz, 2000 Hz, and TSL = 10, 30, 50, 70, 100 ms, respectively.  
All in vivo rat MR images were acquired by horizontal 7.0-T spectrometer (PharmaScan 
70/16, Bruker, Germany) equipped with a 372-mm birdcage transmitter coil and a separate 
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quadratic surface coil for signal detection and active shielding gradient of 300 mT/m in 80 μs. 
Images were acquired by the fast spin echo pulse sequence (Figure 3A) with TR = 3 s, 
TE = 60 ms, FOV = 2.56 cm × 2.56 cm, matrix size = 256 × 128, and slice thickness = 1 mm. 
 
4.4. In Vivo MR Imaging Analysis 
 Because the U87MG cells were implanted into the right brain, the mean intensity and 
standard deviation (STD) of the left side of the bilaterally symmetric brain were calculated. Then 
the normal brain tissue area was selected from the range of mean ± 3 × STD to avoid the 
extremely high/low intensity signals from certain characteristic regions in the brain, such as 
lateral ventricle (contains cerebrospinal ﬂuid), corpus callosum, etc., as they have very different 
MR parameters compared to the rest of the brain. 
The region of interest for the GBM was defined by images and mappings acquired by 
more sensitive MR methods with superior contrast and low SAR developed in our lab [38-44], 
and the location of the GBM was also confirmed by histopathology slides taken after the animals 
were sacrificed at late stage.  
For all MR images, contrast-to-noise ratios (CNR) is calculated based on: 
Equation 1. 
CNR =  
|S(tumor) − S(brain)|
σ(noise)
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where S(tumor) and S(brain) are the average signal intensities for the tumor (in the right brain) 
and the normal brain tissue (in the left brain), respectively, and σ(noise) is the standard deviation 
of the image noise. 
 
4.5. Early GBM Simulation Model 
To mimic early GBM microenvironment, our simple, computationally efficient 
theoretical model was based on the experimental observation that vessel density decreases 
together with the increase of vessel size during the early stage of the GBM growth [15]. It 
consisted of a voxel cube with parallel infinite vessel-cylinders representing blood vessels 
distributed uniformly inside. The total volume of the vessel-cylinders was kept constant and the 
cube volume was determined by the BVf. From [15], BVf was taken as 0.04. The vessel radius, 
R, was set to be 9×10
−6
√N
 m, where N is the number of vessel-cylinders distributed uniformly inside 
the voxel cube. N decreased during the GBM growth. Each infinite vessel cylinder contributed 
an induced dipolar field, ωB, at position r̅ along the direction of the externally applied static 
superconducting magnetic field, Bo [14]: 
Equation 2. 
ωB =
{
 
 
 
 2π∆χ(1 − Y)
B0
γ
sin2(θ) (
R
r
)
2
cos(2φ) , r > R
2π∆χ(1 − Y)
B0
γ
(cos2(θ) −
1
3
) , r < R
 
where J is the 1H gyromagnetic ratio, (1 - Y) is the degree of deoxygenation of the blood 
(assumes the value of 0.3 [15]), θ is the angle between the vessel-cylinder orientation and Bo, R 
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is the vessel-cylinder radius, r is the shortest distance to the vessel-cylinder center of interest, ϕ is 
the angle between r̅ and the projection of the external static superconducting magnetic field onto 
the plane perpendicular to the vessel cylinder orientation, and 'χ is the susceptibility difference 
between entirely deoxygenated blood and entirely oxygenated blood (assumes the value of 0.15 
ppm [24]). 
 
4.6. Monte Carlo Spin Dynamics Simulations 
 To optimize the efficiency and accuracy of the spin dynamics simulations, two different 
simulation methods were carried out to evolve the water magnetizations under the spin-echo and 
the CPMG pulse sequences. Initially 4000 water magnetizations were randomly distributed 
inside the cube for Method 1 and on a plane perpendicular to the vessel-cylinders for Method 2. 
During the random walk process that mimics the water diffusion, each step was taken as a 
random vector on a sphere for Method 1 or on a circle for Method 2 with step-size determined by 
three-dimensional [44] or two-dimensional diffusions, respectively. The transverse 
magnetization of the diffusing water magnetizations dephased due to local field inhomogeneity 
induced by paramagnetic deoxyhemoglobin inside blood vessels [45]. The water diffusion 
coefficient, D, was taken as 1×10-5 cm2 s-1 and the time-step, 't, was taken as 0.05 ms. Small 
time-steps are required to make sure that water magnetizations sufficiently sample the induced 
dipolar fields and will not jump over the vessel-cylinders in a few steps. The vessel-cylinders 
were assumed to be impermeable for water diffusion. Random-walk steps that penetrated vessel-
cylinders were repeated until a collision-free step was generated. By assuming the spatial 
periodicity of voxels, periodic boundary condition was applied. Water magnetizations that 
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walked out of the voxel re-entered from the opposite side of the voxel cube. To study the effect 
of vessel-cylinder aggregation, simulations were repeated with uniform distributions of N = 1, 2, 
4, and 9 vessel cylinders, respectively. Simulation results were averaged over 16 θ angles 
between 0 and S, weighted by sin(θ). All simulations were programmed using Matlab (The 
Mathworks Inc.). 
 
4.7. Simulation Method 1 – Analytical Method 
 The Bloch equation describes the classical spin dynamics of a spin magnetization M = 
Mx i + My j + Mz k in the presence of a magnetic field B = Bx i + By j + Bz k, where {i, j, k} 
are the unit vectors of the Cartesian coordinate system. Via a complete analytical solution of the 
Bloch equation [46], exact time evolution of a spin magnetization M(t) for each step with 
duration time ∆𝑡 during diffusion can be obtained by applying the propagator U(∆𝑡, 0): 
 Equation 3. 
M(∆𝑡) = U(∆𝑡, 0) M(0) 
U(∆𝑡, 0) = 𝑒−Γ∆𝑡 
Γ =
[
 
 
 
 
 
 
1
𝑇2
−𝛾𝐵𝑧 𝛾𝐵𝑦
𝛾𝐵𝑧
1
𝑇2
−𝛾𝐵𝑥
−𝛾𝐵𝑦 𝛾𝐵𝑥
1
𝑇1 ]
 
 
 
 
 
 
 
where -Γ is the matrix form of the system of Bloch equations for the magnetization components 
{Mx, My, Mz}, T1 is the longitudinal relaxation time constant, and T2 is the transverse relaxation 
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time constant. Denote the direction of the external superconducting Zeeman field, Bo, as the z-
direction. For the spin-echo pulse sequence, the sign of the water magnetizations along x- and z-
directions was inverted by the 180o pulse at TE/2. For the CPMG pulse sequence, the sign of the 
water magnetizations along x- and z- directions was inverted by the 180o pulses at WCP, 3WCP, 
5WCP,... where WCP = 8 ms. For the spin-locking pulse sequence, a constant locking field was 
applied along the y-direction. 
 
4.8. Simulation Method 2 – Phase Accumulation Method 
 For the spin-echo and the CPMG pulse sequences, since the water magnetizations evolve 
entirely on the transverse plan, the phase accumulation method was used to significantly speed 
up the calculations [14, 26, 47], with additional modification to include background transverse 
relaxation. At each time step, 't, every water magnetization experienced different induced 
magnetic field which depended on its position r̅  and underwent a phase shift, ∆ϕ(r̅)= ∆ω(r̅)*'t. 
The accumulated phase shift, ), was calculated by summing up individual phase shift produced 
at each random-walk step: 
Equation 4. 
Φ = ∑ ∆ϕ(r̅n)
step
n = 1 
 
The accumulated phase shift for the jth water magnetization, )j, gave the information on 
the rotation of the jth water magnetization on the transverse plane. With additional phase factor, 
ei) or cos()), the average water magnetization of the voxel, S(t), was determined as: 
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Equation 5. 
S(𝑡) ≈  |
∑ eiΦj(t)j=magnetization
∑ eiΦ0j=magnetization
| =  |
∑ sj(t)j=magnetization
∑ s0j=magnetization
| =  |< sj(t) >| 
where )o denotes the initial phase on the transverse plane after the first S/2 excitation pulse. 
Here we assumed )o = 0. The additional weighting factor of sin(θ) over the vessel-cylinder angle 
θ and the sign flip of magnetization components by the 180o pulse were identical to the previous 
method. 
 
4.9. Simulation Method 3 – ODE Solver 
 The evolution of the water magnetizations were obtained by numerically solving the 
Bloch equation with the Matlab ordinary differential equation solver, ode45. This method is 
accurate, robust, but very time-consuming. 
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5. Conclusions 
In conclusion, spin systems of in vivo orthotopic GBM mouse models infected with 
U87MG cell line and orthotopic GBM rat models infected with C6 cell line were prepared by the 
spin-echo, the CPMG, and the spin-locking pulse sequences to high contrast states and then 
acquired by the fast spin-echo pulse sequence. For early-stage GBM mouse models (within 15 
days after U87MG cells implantation), statistical results (N = 18) showed that, while the spin-
echo T2-weighted MR imaging may not provide the required contrast to detect early GBM, the 
CPMG T2-weighted MR imaging with short inter-pulse spacing (e.g., τCP = 1 ms) and the spin-
locking T1U-weighted MR imaging with high locking-field (e.g., B1 = 2000 Hz) slightly improve 
early GBM contrast but at the cost of significantly elevated specific absorption rate (SAR) and 
increased potential risk, if applied to human patients. 
To facilitate the development of innovative MRI pulse sequences to enhance early GBM 
contrast with acceptable SAR, a simple theoretical model on early GBM was proposed based on 
the BOLD mechanism and the experimental observation that vessel density decreases together 
with the increase of vessel size during the early stage of the GBM growth. Using the proposed 
model, Monte Carlo spin dynamics simulations were carried out by solving the Bloch equations 
for the water magnetizations diffusing in the magnetic-field gradients induced by paramagnetic 
deoxyhemoglobin in the vessels under specific RF pulse sequences with various algorithms for 
computational efficiency and accuracy. The interplay among the spin dynamics, GBM contrast, 
RF pulse sequences used for imaging, vessel distributions, and GBM staging can be numerically 
evaluated. The simulated early GBM contrast and the relaxation time constants, T2 and T1U, from 
the spin-echo, the CPMG, and the spin-locking RF pulse sequences were compared with those 
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from the in vivo MR imaging of orthotopic early GBM mouse models to study the relaxation 
mechanisms. Our simulation results showed semi-quantitative and qualitative agreement with in 
vivo MR images during the GBM growth and thus this simple model provides a computationally 
efficient alternative for laboratory use of animals following the 3R (reduction, refinement and 
replacement) strategy in evaluating the performance of commonly use or newly developed MR 
methods for early GBM detection. Among various innovative MRI methods, we are particularly 
interested in and committed to the active-feedback methods based on non-linear spin dynamics 
[38-43], as have been demonstrated in subcutaneous colon cancer case [44]. Further applications 
of the active-feedback and fixed-point methods to GBM early detection are currently under 
intensive investigation in our lab. The proposed theoretical model shall be refined to incorporate 
more detailed information and complicated dynamics on early GBM such as the vessels 
becoming more disorganized and randomly oriented when GBM grows, changes in the diffusion 
coefficient of water magnetizations, the increase of vascularization in the periphery, and the MT 
effect. 
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